Medications
Bone loss medicines linked to lower ovarian cancer rates
Medicines used to prevent bone loss may help lower the risk of ovarian cancer according to research by The University of Queensland.
Jun 17, 2022
0
5
Ovarian Cancer
Oncology & Cancer
Insights into breast cancer gene that could lead to better risk screening
Inherited mutations in the BRCA1 gene can significantly increase a person's risk of breast and ovarian cancer—but not every mutation in the gene is harmful. To better equip patients and their doctors to understand and manage ...
Jun 03, 2022
0
33
Oncology & Cancer
Vitamin D may restore the body's natural barrier against ovarian cancer
Ovarian cancer has one of the highest death rates of all cancers. One reason for this is that the cancer turns the body's defenses against itself. However, new research from Nagoya University published in Matrix Biology suggests ...
May 31, 2022
0
261
Obstetrics & gynaecology
Appearance of ovarian lesions on ultrasound may predict malignancy
The appearance of ovarian lesions on ultrasound may predict the risk for malignancy, according to a study published in the June issue of Radiology.
May 27, 2022
0
3
Medications
Next-generation immunotherapy drug shows continued promise in several advanced-stage cancers
Initial study results show that an experimental drug, called nemvaleukin alfa, when used alone or in combination with another anticancer drug (pembrolizumab) may be effective in treating several types of late-stage cancers ...
May 26, 2022
0
20
Oncology & Cancer
New GP-administered blood test could help diagnose ovarian cancer faster and more accurately
A simple blood test that can be given by general practitioners (GPs) could help diagnose ovarian cancer faster and more accurately, particularly for women under the age of 50, according to research funded by leading women's ...
May 05, 2022
0
15
Oncology & Cancer
Researcher concludes five-year multisite trial to assess lymphedema prevention
Vanderbilt University Research Professor of Nursing Sheila Ridner recently completed a large, randomized trial to assess early detection methods for a common side effect of breast-cancer treatments—lymphedema.
Apr 28, 2022
0
9
Medical research
Regulator of cancer 'stemness' discovered
The protein FOXK2 promotes survival of cancer stem cells in ovarian cancer, according to a Northwestern Medicine study published in the Journal of Clinical Investigation.
Apr 27, 2022
0
38
Oncology & Cancer
Ovarian cancer is not a silent killer. Recognizing symptoms could help reduce misdiagnosis and late detection
Ovarian cancer is the most deadly of gynecologic tumors. Fewer than 40% of those diagnosed with ovarian cancer are cured, and approximately 12,810 people in the U.S. die from the disease every year.
Apr 26, 2022
0
2
Immunology
A new toolkit to engineer safe and efficient therapeutic cells
Therapies based on engineered immune cells have recently emerged as a promising approach in the treatment of cancer. Compared to traditional drugs, engineered immune cells are more precise and sophisticated in their ability ...
Apr 15, 2022
0
27
Ovarian cancer is a cancerous growth arising from the ovary. Symptoms are frequently very subtle early on and may include: bloating, pelvic pain, difficulty eating and frequent urination, and are easily confused with other illnesses.
Most (more than 90%) ovarian cancers are classified as "epithelial" and are believed to arise from the surface (epithelium) of the ovary. However, some evidence suggests that the fallopian tube could also be the source of some ovarian cancers. Since the ovaries and tubes are closely related to each other, it is thought that these fallopian cancer cells can mimic ovarian cancer. Other types may arise from the egg cells (germ cell tumor) or supporting cells. These cancers are grouped into the category of gynecologic cancer.
This text uses material from Wikipedia licensed under CC BY-SA
